← The Wire
DNLINasdaq
Denali Therapeutics Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1714899
Denali Therapeutics discovers, develops, and delivers biotherapeutics for serious diseases, including brain disorders, using proprietary barrier-crossing technology
$3.44B
Market cap
$25.89
Last close
+1.3%
1D
+7.7%
5D
2.2M
Volume
Price · last 39 sessions+38.7%
May 4L $18.11 · H $25.89Jun 29
176
Total filings
Jun 18, 2026
Last filing
12/31
Fiscal year end
8-KMaterial Agreement · Reg FD DisclosureJun 18, 20268-KShareholder VoteJun 4, 20268-KReg FD DisclosureMay 22, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14A ADDITIONAL MATERIALSApr 21, 2026DEF 14ADEF 14AApr 21, 20268-KAgreement TerminatedApr 3, 20268-KNew Debt / Obligation · Reg FD DisclosureMar 31, 20268-KReg FD DisclosureMar 25, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KReg FD DisclosureJan 6, 20268-KMaterial Agreement · Company UpdateDec 10, 2025424B5424B5Dec 10, 2025424B5424B5Dec 9, 20258-KReg FD Disclosure · Company UpdateDec 4, 20258-KMaterial AgreementDec 4, 202510-Q10-QNov 6, 20258-KResults of OperationsNov 6, 20258-KReg FD DisclosureOct 14, 202510-Q10-QAug 11, 20258-KResults of OperationsAug 11, 20258-KReg FD DisclosureJul 7, 20258-KMaterial Agreement · Shareholder VoteJun 3, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFA14AApr 17, 2025DEF 14ADEF 14AApr 17, 20258-KReg FD DisclosureApr 2, 20258-KReg FD DisclosureMar 5, 20258-KMaterial Agreement · Agreement TerminatedFeb 27, 202510-K10-KFeb 27, 20258-KReg FD DisclosureJan 13, 20258-KReg FD DisclosureJan 7, 20258-KBylaw AmendmentNov 18, 2024SC 13GSEC SCHEDULE 13GNov 12, 202410-Q10-QNov 6, 20248-KResults of OperationsNov 6, 20248-KReg FD DisclosureOct 10, 2024SC 13GSC 13GAug 16, 202410-Q10-QAug 1, 20248-KResults of OperationsAug 1, 20248-KShareholder VoteMay 31, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 18, 2024DEF 14ADEF 14AApr 18, 202410-K10-KFeb 28, 20248-KResults of OperationsFeb 27, 20248-KMaterial Agreement · Equity IssuanceFeb 27, 20248-KReg FD DisclosureFeb 16, 2024SC 13GSEC SCHEDULE 13GFeb 8, 20248-KReg FD DisclosureJan 8, 202410-Q10-QNov 7, 20238-KResults of OperationsNov 7, 20238-KMaterial AgreementAug 21, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 20238-KCompany UpdateJun 20, 20238-KCompany UpdateJun 5, 20238-KShareholder VoteJun 2, 202310-Q10-QMay 8, 20238-KResults of OperationsMay 8, 2023DEFA14ADEFA14AApr 18, 2023DEF 14ADEF 14AApr 18, 2023SC 13GSC 13GMar 30, 202310-K10-KFeb 27, 20238-KResults of OperationsFeb 27, 20238-KReg FD DisclosureJan 9, 202310-Q10-QNov 3, 20228-KResults of OperationsNov 3, 20228-KMaterial Agreement · Company UpdateOct 20, 2022424B5424B5Oct 20, 20228-KResults of Operations · Company UpdateOct 18, 2022424B5424B5Oct 18, 202210-Q10-QAug 8, 20228-KResults of OperationsAug 8, 20228-KReg FD DisclosureJul 5, 20228-KShareholder VoteJun 3, 2022
Insider Activity
In the 90 days to Jan 6, 2026: 2 sold $865K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 6, 2026 | Watts Ryan J.President and CEO | Sell | 35,198 | $16.50 | $581K |
| Jan 6, 2026 | Schuth Alexander O.COFO and Secretary | Sell | 17,218 | $16.50 | $284K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance